The prevalent enrichment of the DNA replication and PI3K/MTOR signaling pathways across both risk groups is particularly notable, as these pathways are critically involved in tumor cell proliferation, survival, and resistance to treatment. This evidence concerns the gene MTOR and neoplasm.